Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand

References

• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation. 2016;133(4):e38–360.
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–892. doi:10.1002/ejhf.319
   PubMed Web of Science ®Google Scholar
• Summary report of morbidity A.D.2015. Bureau of policy and strategy MoP, editor. Bangkok: Samcharoen Panich; 2016.
   Google Scholar
• Krittayaphong R, Karaketklang K, Yindeengam A, Janwanishstaporn S. Heart failure mortality compared between elderly and non-elderly Thai patients. J Geriatr Cardiol. 2018;15(12):718–724.
   Google Scholar
• Kim SJ, Park EC, Kim TH, Yoo JW, Lee SG. Mortality, length of stay, and inpatient charges for heart failure patients at public versus private hospitals in South Korea. Yonsei Med J. 2015;56(3):853–861. doi:10.3349/ymj.2015.56.3.853
   Web of Science ®Google Scholar
• Robertson J, McElduff P, Pearson S-A, Henry DA, Inder KJ, Attia JR. The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Serv Res. 2012;12:103. doi:10.1186/1472-6963-12-103
   Web of Science ®Google Scholar
• Teng TK, Tromp J, Tay WT, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health. 2018;6(9):e1008–e1018. doi:10.1016/S2214-109X(18)30306-1
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200.
   PubMed Web of Science ®Google Scholar
• Chantrarat T, Yingchoncharoen T, Kanjanavanich R, Kanjanavanich R, Ayudhya R, Porapakkham P. Heart Failure Council of Thailand (HFCT) 2019 heart failure guideline: sudden cardiac death and device therapy in heart failure. J Med Assoc Thai. 2019;102(5):618–622.
   Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–1549. doi:10.1056/NEJMoa050496
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–2150. doi:10.1056/NEJMoa032423
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–1853. doi:10.1056/NEJMoa013168
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39(12):2026–2033. doi:10.1016/S0735-1097(02)01895-8
   PubMed Web of Science ®Google Scholar
• Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289(6):730–740. doi:10.1001/jama.289.6.730
   PubMed Web of Science ®Google Scholar
• Bertoldi EG, Rohde LE, Zimerman LI, Pimentel M, Polanczyk CA. Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country’s public health system. Int J Cardiol. 2013;163(3):309–315. doi:10.1016/j.ijcard.2011.06.046
   PubMed Web of Science ®Google Scholar
• Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol. 2005;46(12):2311–2321. doi:10.1016/j.jacc.2005.08.033
   PubMed Web of Science ®Google Scholar
• Callejo D, Guerra M, Hernández-Madrid A, Blasco JA. Economic assessment of cardiac resynchronization therapy. Rev Esp Cardiol. 2010;63(11):1235–1243. doi:10.1016/S0300-8932(10)70293-1
   Web of Science ®Google Scholar
• Aidelsburger P, Grabein K, Klauss V, Wasem J. Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective. Clin Res Cardiol. 2008;97(2):89–97. doi:10.1007/s00392-007-0586-9
   Web of Science ®Google Scholar
• Shah D, Lu X, Paly VF, Sintzos SI, May DM. Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data. J Med Econ. 2020;23(7):690–697. doi:10.1080/13696998.2020.1746316
   PubMed Web of Science ®Google Scholar
• Fox M, Mealing S, Anderson R, et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess. 2007;11(47):iii–iv, ix-248. doi:10.3310/hta11470
   Web of Science ®Google Scholar
• Colquitt JL, Mendes D, Clegg AJ, et al. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation. Health Technol Assess. 2014;18(56).
   Web of Science ®Google Scholar
• Janwanishstaporn S. National trend, in-hospital and long term outcomes in the hospitalized heart failure patients in Thailand. Thai Heart J. 2015;28:128.
   Google Scholar
• Adena MA, Hamann G, Sindone AP. Cost-effectiveness of ivabradine in the treatment of chronic heart failure. Heart Lung Circ. 2019;28(3):414–422. doi:10.1016/j.hlc.2018.01.011
   PubMed Web of Science ®Google Scholar
• Reyes EB, Ha JW, Firdaus I, et al. Heart failure across Asia: same healthcare burden but differences in organization of care. Int J Cardiol. 2016;223:163–167. doi:10.1016/j.ijcard.2016.07.256
   PubMed Web of Science ®Google Scholar
• Bank of Thailand. Foreign exchange rates. 2020 [cited June 15, 2020]. Available from: https://www.bot.or.th/english/statistics/financialmarkets/exchangerate/_layouts/application/exchangerate/ExchangeRate.aspx.
   Google Scholar
• Permsuwan U, Guntawongwan K, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thai. 2014;97(Suppl 5):S50–58.
   PubMedGoogle Scholar
• Limwattananon S. Sensitivity analysis for handling uncertainty in an economic evaluation. In: Chaikledkaew U, Teerawattananon Y, editors. Guidelines for Health Technology Assessment in Thailand. 2nd ed. Nonthaburi: Wacharin; 2013:105–119.
   Google Scholar
• Calvert MJ, Freemantle N, Yao G, et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005;26(24):2681–2688. doi:10.1093/eurheartj/ehi662
   PubMed Web of Science ®Google Scholar
• Fang F, Jie ZY, Xia LX, et al. Cardiac resynchronisation therapy and heart failure: persepctive from 5P medicine. Card Fail Rev. 2015;1(1):35–37. doi:10.15420/CFR.2015.01.01.35
   Google Scholar
• Normand C, Linde C, Singh J, Dickstein K. Indications for cardiac resynchronization therapy. JACC Heart Fail. 2018;6(4):308.
   Web of Science ®Google Scholar
• Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42(8):1454–1459. doi:10.1016/S0735-1097(03)01042-8
   PubMed Web of Science ®Google Scholar
• Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(1):111–118. doi:10.1016/S0735-1097(02)01932-0
   Web of Science ®Google Scholar
• Hernández-Madrid A, Lu X, Tsintzos SI, et al. Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US setting. Clinicoecon Outcomes Res. 2019;11:385–393. doi:10.2147/CEOR.S205501
   PubMed Web of Science ®Google Scholar
• Guo Y, Lip GYH, Banerjee A. Heart failure in East Asia. Curr Cardiol Rev. 2013;9(2):112–122.
   Google Scholar
• Bundhamcharoen K, Aungkulanon S. Burden of Disease in Thai Population 2009. International Health Policy Program; 2012.
   Google Scholar
• Health Statistics, Strategy and Planning Division, Ministry of Public Health. Mortality rate per 100,000 Thai population by causes of death during 1998–2016. 2016 [cited February 2, 2018]. Available from: http://social.nesdb.go.th/SocialStat/StatReport_Final.aspx?reportid=441&template=2R1C&yeartype=M&subcatid=15.
   Google Scholar
• Neyt M, Stroobandt S, Obyn C, et al. Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model. BMJ Open. 2011;1(2):e000276. doi:10.1136/bmjopen-2011-000276
   PubMed Web of Science ®Google Scholar